INSIGHTS ON DRUG DEVELOPMENT

• Closing The QC Gap For mAbs: Rapid Answers Without Compromising

  Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

• ITC For Binding Characterization In Pharmaceutical Research

  Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

• Integrating Phase-Appropriate Quality Standards

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.

• Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling

  7/15/2026

  Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.

• VEGF Signaling Pathway

  3/24/2025

  In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

• Spray Dried Dispersions In Controlled Release Formulations

  10/16/2025

  Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

• Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles

  7/1/2026

  Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.

• Managing Process Knowledge Throughout Drug Development And Manufacturing

  10/21/2025

  Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.